Es gab 50 kürzliche Insider-Transaktionen für Verve Therapeutics, Inc. (VERV), darunter 29 Käufe und 18 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $9.37M und die gesamten Insider-Verkäufe auf $1.35M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Adelman Burt A, Maclean Michael F, Yeshwant Krishna. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — VERV
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-06-05 |
Adelman Burt A |
Director |
RSU-Zuteilung |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Maclean Michael F |
Director |
RSU-Zuteilung |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Yeshwant Krishna |
10 Percent Owner |
RSU-Zuteilung |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Coats Lonnel |
Director |
RSU-Zuteilung |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Morrison Jodie Pope |
Director |
RSU-Zuteilung |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Cumbo Alexander |
Director |
RSU-Zuteilung |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Tatsis Ourania |
Director |
RSU-Zuteilung |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Mikhail Sheila |
Director |
RSU-Zuteilung |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-04-02 |
Ashe Andrew D. |
See Remarks |
Informierter Verkauf |
2,681 |
$4.15 |
$11.13K |
348,828 |
| 2025-04-02 |
Dorval Allison |
Chief Financial Officer |
Informierter Verkauf |
3,350 |
$4.15 |
$13.9K |
13,280 |
| 2025-04-02 |
Kathiresan Sekar |
Chief Executive Officer |
Informierter Verkauf |
9,822 |
$4.15 |
$40.76K |
346,686 |
| 2025-04-02 |
Nickerson Joan |
Chief Administrative Officer |
Informierter Verkauf |
2,777 |
$4.15 |
$11.52K |
17,420 |
| 2025-04-02 |
Lister Troy |
Chief Scientific Officer |
Informierter Verkauf |
2,189 |
$4.15 |
$9.08K |
6,952 |
| 2025-04-02 |
Politi Jason |
Chief Technical Ops. Off. |
Informierter Verkauf |
3,235 |
$4.15 |
$13.43K |
14,226 |
| 2025-04-01 |
Ashe Andrew D. |
See Remarks |
Optionsausübung (Verkauf) |
9,000 |
- |
- |
27,000 |
| 2025-04-01 |
Dorval Allison |
Chief Financial Officer |
Optionsausübung |
11,250 |
- |
- |
16,630 |
| 2025-04-01 |
Kathiresan Sekar |
Chief Executive Officer |
Optionsausübung (Verkauf) |
33,000 |
- |
- |
99,000 |
| 2025-04-01 |
Nickerson Joan |
Chief Administrative Officer |
Optionsausübung (Verkauf) |
3,315 |
- |
- |
6,630 |
| 2025-04-01 |
Lister Troy |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
3,315 |
- |
- |
6,630 |
| 2025-04-01 |
Politi Jason |
Chief Technical Ops. Off. |
Optionsausübung (Verkauf) |
3,315 |
- |
- |
6,630 |
| 2025-01-08 |
Ashe Andrew D. |
See Remarks |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2025-01-08 |
Dorval Allison |
Chief Financial Officer |
RSU-Zuteilung |
45,000 |
- |
- |
45,000 |
| 2025-01-08 |
Kathiresan Sekar |
Chief Executive Officer |
RSU-Zuteilung |
120,000 |
- |
- |
120,000 |
| 2025-01-08 |
Nickerson Joan |
Chief Administrative Officer |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2025-01-08 |
Lister Troy |
Chief Scientific Officer |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2025-01-08 |
Politi Jason |
Chief Technical Ops. Off. |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2024-12-04 |
Kathiresan Sekar |
Chief Executive Officer |
Schenkung (erhalten) |
30,000 |
- |
- |
110,997 |
| 2024-12-02 |
Dorval Allison |
Chief Financial Officer |
Informierter Verkauf |
555 |
$5.64 |
$3.13K |
5,380 |
| 2024-11-29 |
Dorval Allison |
Chief Financial Officer |
Optionsausübung (Verkauf) |
1,875 |
- |
- |
1,875 |
| 2024-06-28 |
Kathiresan Sekar |
Chief Executive Officer |
Optionsausübung (Verkauf) |
30,000 |
$2.87 |
$86.1K |
215,308 |
| 2024-06-26 |
Adelman Burt A |
Director |
RSU-Zuteilung |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Maclean Michael F |
Director |
RSU-Zuteilung |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Yeshwant Krishna |
10 Percent Owner |
RSU-Zuteilung |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Coats Lonnel |
Director |
RSU-Zuteilung |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Morrison Jodie Pope |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-06-26 |
Morrison Jodie Pope |
Director |
RSU-Zuteilung |
267,541 |
$5.02 |
$1.34M |
267,541 |
| 2024-06-26 |
Cumbo Alexander |
Director |
RSU-Zuteilung |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Tatsis Ourania |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-06-26 |
Tatsis Ourania |
Director |
RSU-Zuteilung |
267,541 |
$5.02 |
$1.34M |
267,541 |
| 2024-06-26 |
Mikhail Sheila |
Director |
RSU-Zuteilung |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Politi Jason |
Chief Technical Ops. Off. |
Veräußerung |
90,000 |
$12.75 |
$1.15M |
- |
| 2024-06-21 |
Lister Troy |
Chief Scientific Officer |
Veräußerung |
16,100 |
- |
- |
- |
| 2024-06-21 |
Lister Troy |
Chief Scientific Officer |
RSU-Zuteilung |
32,000 |
$5.29 |
$169.28K |
32,000 |
| 2024-05-14 |
Ashe Andrew D. |
See Remarks |
Informierter Kauf |
76,000 |
$6.26 |
$475.76K |
342,509 |
| 2024-04-02 |
Nickerson Joan |
Chief Administrative Officer |
Informierter Verkauf |
1,514 |
$8.24 |
$12.48K |
8,659 |
| 2024-04-01 |
Nickerson Joan |
Chief Administrative Officer |
Optionsausübung (Verkauf) |
3,315 |
- |
- |
9,945 |
| 2024-02-14 |
Ashe Andrew D. |
See Remarks |
RSU-Zuteilung |
36,000 |
- |
- |
36,000 |
| 2024-02-14 |
Dorval Allison |
Chief Financial Officer |
RSU-Zuteilung |
45,000 |
- |
- |
45,000 |
| 2024-02-14 |
Fiedorek Fred T. |
Chief Medical Officer |
RSU-Zuteilung |
22,000 |
- |
- |
22,000 |
| 2024-02-14 |
Kathiresan Sekar |
Chief Executive Officer |
RSU-Zuteilung |
132,000 |
- |
- |
132,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
